GlassScriptPhysician profile
Amanda Gonzalez
NPI 1497101679
$8,231.48
in general payments reported to CMS, 2019-2025
32 companies · $1,773 in 2025
The $1,773 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $757 · 2023: $3,287 · 2024: $2,287 · 2025: $1,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,281 · Education: $66.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,280.53 |
| Education | $66.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,739.76 | 2022-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $1,621.60 | 2022-2025 | |
| Amgen INC. | $1,200.08 | 2022-2025 | Krystexxa, Tavneos, Enbrel |
| Astrazeneca Pharmaceuticals LP | $793.67 | 2022-2025 | Saphnelo, Flumist Quadrivalent |
| Lilly USA, LLC | $619.11 | 2022-2024 | Taltz, Zepbound |
| Pfizer INC. | $236.33 | 2022-2024 | |
| Ucb, INC. | $233.59 | 2024-2025 | Bimzelx |
| Horizon Therapeutics Plc | $206.11 | 2023 | Krystexxa |
| Nevro Corp. | $199.95 | 2023 | Senza |
| Aurinia Pharma U.S., INC. | $186.34 | 2023-2024 | Lupkynis |
| Inspire Medical Systems, INC. | $149.92 | 2024 | Inspire |
| Globus Medical, INC. | $144.92 | 2025 | Senza |
| Genzyme Corporation | $139.25 | 2023 | |
| Galderma Laboratories, L.P. | $119.76 | 2022-2024 | |
| Si-Bone, INC. | $94.13 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $76.20 | 2023-2024 | Orencia |
| Tonix Medicines, INC. | $67.05 | 2025 | Tonmya |
| Emd Serono, INC. | $56.56 | 2021 | |
| Octapharma USA, INC. | $52.40 | 2023-2024 | Octagam Immune Globulin (Human) |
| Smith+Nephew, INC. | $41.41 | 2021 | |
| Medtronic, INC. | $37.41 | 2025 | Stealthstation S8 Platform |
| Fresenius Kabi USA, LLC | $31.68 | 2023-2024 | Idacio |
| Radius Health, INC. | $28.71 | 2023-2024 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.02 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $21.66 | 2025 | Menopur |
| Ani Pharmaceuticals, INC. | $17.62 | 2025 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $17.23 | 2024 | Trintellix |
| Convatec INC. | $16.27 | 2021 | |
| Organon LLC | $14.04 | 2025 | Hadlima |
| Teva Pharmaceuticals USA, INC. | $14.04 | 2023 | Truxima |
| Cumberland Pharmaceuticals, INC. | $13.89 | 2022 | |
| Kci USA, INC. | $13.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.